Natural Alternatives International, Inc.

NasdaqGM:NAII

Market Cap

USD 21.18 M

Share Price

USD 3.22

Avg Daily Volume

13,041

Change (1 day)

-6.94%

Change (1 year)

-47.81%

Change (YTD)

-25.29%

Natural Alternatives International, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 125.48 M

Natural Alternatives International, Inc. Revenue is USD 125.48 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 4.42% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Natural Alternatives International, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 120.17 M, a -29.58% change year over year.
  • Natural Alternatives International, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 170.65 M, a 4.80% change year over year.
  • Natural Alternatives International, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 162.83 M, a -3.78% change year over year.
  • Natural Alternatives International, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 169.22 M, a 48.39% change year over year.
Key data
Date Revenue Revenue Gross Profit Operating Income
Market news
Loading...
NasdaqGM: NAII

Natural Alternatives International, Inc.

CEO Mr. Mark A. LeDoux J.D.
IPO Date Oct. 28, 1993
Location United States
Headquarters 1535 Faraday Avenue
Employees 296
Sector 🏥 Health Care
Industries
Description

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Similar companies

600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.60

0.36%

300146.SZ

By-health Co., Ltd.

USD 1.56

0.02%

600216.SS

Zhejiang Medicine Co., Ltd.

USD 2.01

0.49%

TMO

Thermo Fisher Scientific Inc.

USD 408.28

-0.93%

SDZ.SW

Sandoz Group AG

USD 54.23

1.08%

300999.SZ

Yihai Kerry Arawana Holdings Co., Ltd

USD 4.09

-0.14%

DIVISLAB.NS

Divi's Laboratories Limited

USD 77.89

0.89%

600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.94

-0.23%

ZYDUSLIFE.NS

Zydus Lifesciences Limited

USD 11.49

0.24%

MANKIND.NS

Mankind Pharma Limited

USD 27.30

1.56%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.17

1.98%

300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

USD 7.24

-2.29%

IPN.PA

Ipsen S.A.

USD 120.09

-0.15%

002001.SZ

Zhejiang NHU Company Ltd.

USD 2.96

0.12%

4151.T

Kyowa Kirin Co., Ltd.

USD 16.88

-1.46%

ABBOTINDIA.NS

Abbott India Limited

USD 408.73

5.97%

002422.SZ

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.99

2.33%

2269.T

Meiji Holdings Co., Ltd.

USD 21.82

0.18%

BANB.SW

Bachem Holding AG

USD 73.80

0.64%

FMC

FMC Corporation

USD 42.91

-0.51%

CPF.BK

Charoen Pokphand Foods Public Company Limited

USD 0.68

-0.87%

BCPC

Balchem Corporation

USD 158.35

-0.21%

SFZN.SW

Siegfried Holding AG

USD 111.46

0.81%

1SXP.F

SCHOTT Pharma AG & Co. KGaA

USD 33.16

0.85%

CALM

Cal-Maine Foods, Inc.

USD 99.16

0.59%

000423.SZ

Dong-E-E-Jiao Co.,Ltd.

USD 7.33

0.52%

688336.SS

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.44

-0.33%

IEP

Icahn Enterprises L.P.

USD 8.19

-0.61%

KLBF.JK

PT Kalbe Farma Tbk.

USD 0.09

-0.01%

600873.SS

MeiHua Holdings Group Co.,Ltd

USD 1.50

0.96%

600298.SS

Angel Yeast Co., Ltd

USD 4.87

0.42%

1513.HK

Livzon Pharmaceutical Group Inc.

USD 3.74

1.90%

688278.SS

Xiamen Amoytop Biotech Co., Ltd.

USD 10.05

-0.15%

ALFAA.MX

Alfa, S. A. B. de C. V.

USD 0.72

0.21%

GL9.IR

Glanbia plc

USD 15.28

2.82%

603156.SS

Hebei Yangyuan ZhiHui Beverage Co., Ltd.

USD 2.97

0.02%

0867.HK

China Medical System Holdings Limited

USD 1.53

0.16%

002773.SZ

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 3.99

1.27%

600518.SS

Kangmei Pharmaceutical Co., Ltd.

USD 0.26

-0.07%

ATM.NZ

The a2 Milk Company Limited

USD 5.09

-0.49%

GLAND.NS

Gland Pharma Limited

USD 20.84

-0.35%

7459.T

MediPal Holdings Corporation

USD 16.07

0.09%

BAYERCROP.NS

Bayer CropScience Limited

USD 71.52

3.70%

000623.SZ

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.38

1.05%

4506.T

Sumitomo Pharma Co., Ltd.

USD 6.79

6.37%

ASH

Ashland Inc.

USD 50.70

-0.61%

CONCORDBIO.NS

Concord Biotech Limited

USD 21.33

1.65%

002019.SZ

Yifan Pharmaceutical Co., Ltd.

USD 1.79

-0.84%

9989.HK

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.67

-0.01%

StockViz Staff

June 29, 2025

Any question? Send us an email